Janne Hulkkonen

1.9k total citations
35 papers, 1.4k citations indexed

About

Janne Hulkkonen is a scholar working on Immunology, Physiology and Genetics. According to data from OpenAlex, Janne Hulkkonen has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 11 papers in Physiology and 7 papers in Genetics. Recurrent topics in Janne Hulkkonen's work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Janne Hulkkonen is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Janne Hulkkonen collaborates with scholars based in Finland, Sweden and United States. Janne Hulkkonen's co-authors include Mikko Hurme, Jukka Peltola, Tapani Keränen, Pékka Laippala, Juhani Vilpo, Leena Vilpo, X Y Wang, Sami Kilpinen, Markku M. Nieminen and Arpo Aromaa and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Hypertension and Medicine & Science in Sports & Exercise.

In The Last Decade

Janne Hulkkonen

34 papers receiving 1.4k citations

Peers

Janne Hulkkonen

IMMUN

PHYSI

EPIDE

PMH

Ömer Nurı Pamuk Türkiye

Peter Härle Germany

Shin‐Seok Lee South Korea

Ljudmila Stojanovich Serbia

Rosa Daniela Grembiale Italy

J Jiménez-Alonso Spain

Diana Gómez‐Martín Mexico

Manja Idorn Denmark

Hedi Orbach Israel

S Bombardieri Italy

Ömer Nurı Pamuk Türkiye

Janne Hulkkonen

399 ×0.9

IMMUN

280 ×0.8

PHYSI

248 ×1.0

EPIDE

305 ×1.6

160 ×0.9

PMH

Citations per year, relative to Janne Hulkkonen Janne Hulkkonen (= 1×) peers Ömer Nurı Pamuk

Countries citing papers authored by Janne Hulkkonen

Since Specialization

Citations

This map shows the geographic impact of Janne Hulkkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janne Hulkkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janne Hulkkonen more than expected).

Fields of papers citing papers by Janne Hulkkonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janne Hulkkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janne Hulkkonen. The network helps show where Janne Hulkkonen may publish in the future.

Co-authorship network of co-authors of Janne Hulkkonen

This figure shows the co-authorship network connecting the top 25 collaborators of Janne Hulkkonen. A scholar is included among the top collaborators of Janne Hulkkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janne Hulkkonen. Janne Hulkkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pälve, Kristiina, Janne Hulkkonen, Mika Kähönen, et al.. (2024). Association of childhood socioeconomic status with adulthood maximal exercise blood pressure: the Cardiovascular Risk in Young Finns Study. Blood Pressure. 33(1). 2323987–2323987.

Pälve, Kristiina, Katja Pahkala, Heikki Aatola, et al.. (2017). Cardiorespiratory Fitness and Risk of Fatty Liver. Medicine & Science in Sports & Exercise. 49(9). 1834–1841. 22 indexed citations

Alapirtti, Tiina, et al.. (2009). Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: A video–EEG study. Journal of the Neurological Sciences. 280(1-2). 94–97. 65 indexed citations

Sipilä, Kalle, Mika Kähönen, Antti Jula, et al.. (2009). Interleukin-6 promoter polymorphism and cardiovascular risk factors: The Health 2000 Survey. Atherosclerosis. 207(2). 466–470. 34 indexed citations

Palmio, Johanna, Jaana Suhonen, Tapani Keränen, et al.. (2009). Cerebrospinal fluid tau as a marker of neuronal damage after epileptic seizure. Seizure. 18(7). 474–477. 48 indexed citations

Hulkkonen, Janne, Terho Lehtimäki, Nina Mononen, et al.. (2008). Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study. Atherosclerosis. 203(2). 454–458. 31 indexed citations

Palmio, Johanna, Tapani Keränen, Tiina Alapirtti, et al.. (2008). Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: A video–EEG study. Epilepsy Research. 81(2-3). 155–160. 37 indexed citations

Vilpo, Juhani, Gerard Tobin, Janne Hulkkonen, et al.. (2005). Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells. European Journal Of Haematology. 75(1). 34–40. 3 indexed citations

Hulkkonen, Janne, et al.. (2004). The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients. Epilepsy Research. 59(2-3). 199–205. 80 indexed citations

10.

Karjalainen, Jussi, Janne Hulkkonen, Tanja Pessi, et al.. (2003). Allergic rhinitis and polymorphisms of the interleukin 1 gene complex. Annals of Allergy Asthma & Immunology. 91(3). 275–279. 29 indexed citations

11.

Karjalainen, Jussi, Janne Hulkkonen, Markku M. Nieminen, et al.. (2003). The IL1A genotype is associated with nasal polyposis in asthmatic adults. Allergy. 58(5). 393–396. 42 indexed citations

12.

Aittoniemi, Janne, M. Pertovaara, Janne Hulkkonen, et al.. (2002). The significance of mannan-binding lectin gene alleles in patients with primary Sjo¨gren's syndrome. Scandinavian Journal of Rheumatology. 31(6). 362–365. 12 indexed citations

13.

Vilpo, Juhani, Janne Hulkkonen, Mikko Hurme, & Leena Vilpo. (2002). Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells. Leukemia. 16(9). 1691–1698. 8 indexed citations

14.

Kivekäs, Ilkka, Janne Hulkkonen, Mikko Hurme, Leena Vilpo, & Juhani Vilpo. (2002). CD80 antigen expression as a predictor of ex vivo chemosensitivity in chronic lymphocytic leukemia. Leukemia Research. 26(5). 443–446. 5 indexed citations

15.

Karjalainen, Jussi, Janne Hulkkonen, Tanja Pessi, et al.. (2002). The IL1A genotype associates with atopy in nonasthmatic adults. Journal of Allergy and Clinical Immunology. 110(3). 429–434. 41 indexed citations

16.

Hulkkonen, Janne. (2001). Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. British journal of rheumatology. 40(6). 656–661. 175 indexed citations

17.

Hulkkonen, Janne, M. Pertovaara, Jaakko Antonen, et al.. (2001). Genetic association between interleukin-10 promoter region polymorphisms and primary Sj�gren's syndrome. Arthritis & Rheumatism. 44(1). 176–179. 86 indexed citations

18.

Hulkkonen, Janne, Pékka Laippala, & Mikko Hurme. (2000). A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals.. PubMed. 11(2). 251–5. 109 indexed citations

19.

Antonen, Jaakko, Janne Hulkkonen, Amos Pasternack, & Mikko Hurme. (2000). Interleukin 6 May Be an Important Mediator of Trimethoprim-Induced Systemic Adverse Reaction Resembling Aseptic Meningitis. Archives of Internal Medicine. 160(13). 2066–2066. 11 indexed citations

20.

Hulkkonen, Janne, et al.. (1998). Diminished production of interleukin‐6 in chronic lymphocytic leukaemia (B‐CLL) cells from patients at advanced stages of disease. British Journal of Haematology. 100(3). 478–483. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact